| 3.97 |  +0.09 / +2.32% |
Data as of 4:00pm ET | Day’s Change |
| 3.97 |  0.00 / 0.00% |
Volume: 2.1K |
| Previous close | 3.88 |
| Today’s open | 3.88 |
| Day’s range | 3.87 - 3.99 |
| Volume | 66,241 |
| Average volume (3 months) | 67,552 |
| Market cap | $145.9M |
| Dividend yield | -- |
| Earnings growth (last year) | -114.71% |
| Earnings growth (this year) | -955.00% |
| Earnings growth (next 5 years) | +7.55% |
| Revenue growth (last year) | +1.16% |
| P/E ratio | NM |
| Price/Sales | 3.56 |
| Price/Book | 1.68 |
| Today’s change | Today’s % change | |
|---|---|---|
| HZNPHorizon Pharma Inc | +0.05 | +2.16% |
| OGXIOncoGenex Pharmaceut... | -0.51 | -5.08% |
| ZGNXZogenix Inc | +0.06 | +4.00% |
| ARQLArQule Inc | -0.07 | -2.88% |
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $61.3M |
| Annual profit (last year) | -$1.4M |
| Net profit margin | -2.30% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Michael Cooper Pearce |
Senior Vice President-Research & Development Brian T. Dorsey |
Corporate headquarters The Woodlands, Texas |
.
